Low rate of hepatitis Delta virus co‐infection in first‐time blood donors diagnosed with chronic hepatitis B virus infection in the Netherlands
Transfusion · 2025
DOI: 10.1111/trf.18238 ↗At a glance
Journal article in Transfusion, 2025. Written by Thijs J W van de Laar and 8 co-authors. Institution: Department of Donor Medicine Research, Sanquin Research, Amsterdam, The Netherlands. Major MEDLINE topics: Blood Donors, Coinfection, Hepatitis Delta Virus, Hepatitis B, Chronic. 25 references. Funded by: Gilead Sciences.
Abstract (original language)
Background
Hepatitis Delta virus (HDV) requires co‐infection with hepatitis B virus (HBV) and increases the risk of hepatitis‐related morbidity and mortality compared to HBV mono‐infection. HBV/HDV co‐infected patients will likely benefit from new HDV antiviral drugs, but reliable estimates of co‐infection rates are lacking due to limited HDV testing of HBV‐infected patients. Study Design and Methods First‐time blood and bone tissue donors in the Netherlands (2006–2023) with a newly diagnosed chronic HBV infection were retrospectively tested for HDV antibodies, and for HDV RNA if HDV antibodies were detected. HBV genotyping using phylogenetic analysis was performed to determine the most likely origin of HBV infection.
Results
HBV‐DNA was detected in 254/758.081 (0.034%) first‐time donors in the Netherlands. HBsAg‐positive first‐time donors had a median age of 43 years (IQR: 33–52), were predominantly male (67%), mostly first‐ or second‐generation migrants (76%) and HBV (sub)genotype strongly correlated with the country of birth. HDV testing was performed for 200 first‐time donors with chronic (HBsAg‐positive) HBV infection: 5 donors (2.5%) had HDV antibodies, and 1 donor (0.5%) also had detectable HDV RNA. None of the 17 donors with occult (HBsAg‐negative) HBV infection had experienced HDV infection.
Discussion
Chronic HBV/HDV co‐infection in first‐time donors in the Netherlands is extremely rare, affecting 0.00013% of all first‐time donors, and only 0.5% of HBsAg‐positive first‐time donors consisting predominantly of migrants from high(er) HDV‐endemic countries. Despite low HBV/HDV co‐infection rates, a one‐time HDV reflex testing strategy for HBsAg‐positive patients remains essential to identify patients and to initiate antiviral treatment if needed to reduce the risk of serious liver disease.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Donor Medicine Research, Sanquin Research, Amsterdam, The Netherlands.
- Department of Medical Microbiology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.
- Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands.
- Department of Viroscience, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands.
- Department of Medical Affairs, Sanquin Corporate Staff, Amsterdam, The Netherlands.
- Department of Medical Microbiology, Leiden University Medical Centre, Leiden, The Netherlands.
ORCID profiles: Thijs J W van de Laar, Hans L Zaaijer
Funding
- Gilead Sciences
Cite
APA
van de Laar, T. J. W., Patmore, L. A., Molier, M. M., Sonneveld, M. J., Voermans, J. J. C., Slot, E., Feltkamp, M. C. W., van der Eijk, A. A., & Zaaijer, H. L. (2025). Low rate of hepatitis Delta virus co‐infection in first‐time blood donors diagnosed with chronic hepatitis B virus infection in the Netherlands. Transfusion. https://doi.org/10.1111/trf.18238
Vancouver
van de Laar TJW, Patmore LA, Molier MM, Sonneveld MJ, Voermans JJC, Slot E, et al. Low rate of hepatitis Delta virus co‐infection in first‐time blood donors diagnosed with chronic hepatitis B virus infection in the Netherlands. Transfusion. 2025. doi:10.1111/trf.18238
BibTeX
@article{vandeLaar2025,
author = {van de Laar, Thijs J W and Patmore, Lesley A and Molier, Michel M and Sonneveld, Milan J and Voermans, Jolanda J C and Slot, Ed and Feltkamp, Mariet C W and van der Eijk, Annemiek A and Zaaijer, Hans L},
title = {Low rate of hepatitis Delta virus co‐infection in first‐time blood donors diagnosed with chronic hepatitis B virus infection in the Netherlands},
journal = {Transfusion},
year = {2025},
doi = {10.1111/trf.18238}
}
EUVIMED